Product Images Strensiq

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 17 images provide visual information about the product associated with Strensiq NDC 25682-019 by Alexion Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - strensiq 01

Figure 1 - strensiq 01

Figure A - strensiq 02

Figure A - strensiq 02

Figure - strensiq 03

Figure - strensiq 03

Figure - strensiq 04

Figure - strensiq 04

Figure - strensiq 05

Figure - strensiq 05

Figure - strensiq 06

Figure - strensiq 06

Figure - strensiq 07

Figure - strensiq 07

Figure - strensiq 08

Figure - strensiq 08

Figure - strensiq 09

Figure - strensiq 09

Figure - strensiq 10

Figure - strensiq 10

Figure - strensiq 11

Figure - strensiq 11

Figure - strensiq 12

Figure - strensiq 12

Figure - strensiq 13

Figure - strensiq 13

Figure - strensiq 14

Figure - strensiq 14

This document appears to be a mix of random characters and some recognizable phrases, including medication information for Strensiq (asfotase alfa) Injection. However, much of the information is not readable.*

PRINCIPAL DISPLAY PANEL - 18 mg/0.45 mL Vial Carton - strensiq 15

PRINCIPAL DISPLAY PANEL - 18 mg/0.45 mL Vial Carton - strensiq 15

PRINCIPAL DISPLAY PANEL - 28 mg/0.7 mL Vial Carton - strensiq 16

PRINCIPAL DISPLAY PANEL - 28 mg/0.7 mL Vial Carton - strensiq 16

This appears to be a partially garbled text document with numerous errors and seems to be a combination of random characters, numbers, and letters with no clear context or coherent meaning. Thus, it is not available for evaluation.*

PRINCIPAL DISPLAY PANEL - 40 mg/mL Vial Carton - strensiq 17

PRINCIPAL DISPLAY PANEL - 40 mg/mL Vial Carton - strensiq 17

This appears to be a combination of several unrelated texts, including some errors and gibberish. The first part is not readable and may contain some non-English characters. The second part provides important information about a medication called Strensia, which is an injection containing asfotase alfa, used for subcutaneous administration in patients who weigh 40 kg or more. The medication comes in cartons that contain 12 single-use vials of 80 mg/0.8 mL and should be refrigerated. Any unused portion of the medication should be discarded, and it should not be mixed or diluted with any other solutions.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.